As of today (2024-04-23), Taro Pharmaceutical Industries's share price is $42.23.
Taro Pharmaceutical Industries's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Dec. 2023 was $3.80. Hence, Taro Pharmaceutical Industries's Price-to-Operating-Cash-Flow Ratio for today is 11.11.
The historical rank and industry rank for Taro Pharmaceutical Industries's Price-to-Operating-Cash-Flow or its related term are showing as below:
TARO'
s Price-to-Operating-Cash-Flow Range Over the Past 10 Years
Min: 8.15 Med: 13.01 Max: 104.92
Current: 11.09
During the past 13 years, Taro Pharmaceutical Industries's highest Price-to-Operating-Cash-Flow Ratio was 104.92. The lowest was 8.15. And the median was 13.01.
Taro Pharmaceutical Industries's Cash Flow from Operations per share for the
three
months ended in Dec. 2023 was $0.82.
Its Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Dec. 2023 was $3.80.
During the past 12 months, the average Operating Cash Flow per Share Growth Rate of Taro Pharmaceutical Industries was 771.80% per year.
During the past 3 years, the average Operating Cash Flow per Share Growth Rate was -50.70% per year.
During the past 13 years, Taro Pharmaceutical Industries's highest 3-Year average Operating Cash Flow per Share Growth Rate was 270.90% per year. The lowest was -50.70% per year. And the median was 31.35% per year.
Taro Pharmaceutical Industries Price-to-Operating-Cash-Flow Historical Data
The historical data trend for Taro Pharmaceutical Industries's Price-to-Operating-Cash-Flow can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
|
Taro Pharmaceutical Industries Annual Data
|
|
Trend |
Mar14 |
Mar15 |
Mar16 |
Mar17 |
Mar18 |
Mar19 |
Mar20 |
Mar21 |
Mar22 |
Mar23 |
| Price-to-Operating-Cash-Flow |
|
Get a 7-Day Free Trial
|
|
|
13.02 |
8.67 |
61.56 |
- |
28.78 |
|
Taro Pharmaceutical Industries Quarterly Data
|
|
Mar19 |
Jun19 |
Sep19 |
Dec19 |
Mar20 |
Jun20 |
Sep20 |
Dec20 |
Mar21 |
Jun21 |
Sep21 |
Dec21 |
Mar22 |
Jun22 |
Sep22 |
Dec22 |
Mar23 |
Jun23 |
Sep23 |
Dec23 |
| Price-to-Operating-Cash-Flow |
Get a 7-Day Free Trial
|
|
|
|
|
|
|
|
|
|
|
|
|
66.61 |
28.78 |
14.61 |
11.37 |
10.99 |
Competitive Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, Taro Pharmaceutical Industries's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Taro Pharmaceutical Industries Price-to-Operating-Cash-Flow Distribution
For the Drug Manufacturers industry and Healthcare sector, Taro Pharmaceutical Industries's Price-to-Operating-Cash-Flow distribution charts can be found below:
* The bar in red indicates where Taro Pharmaceutical Industries's Price-to-Operating-Cash-Flow falls into.
Taro Pharmaceutical Industries Price-to-Operating-Cash-Flow Calculation
Taro Pharmaceutical Industries's Price-to-Operating-Cash-Flow ratio for today is calculated as
| Price-to-Operating-Cash-Flow Ratio | = | Share Price | / | Cash Flow from Operations per share (TTM) |
| = | 42.23 | / | 3.801 |
| = | 11.11 |
Taro Pharmaceutical Industries's Share Price of today is $42.23.
Taro Pharmaceutical Industries's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $3.80.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Note: Cash Flow from Operations per share is calculated as Cash Flow from Operations divided by Shares Outstanding (Diluted Average).
It can also be calculated from the numbers for the whole company:
Taro Pharmaceutical Industries (Taro Pharmaceutical Industries) Business Description
Traded in Other Exchanges
Address
14 Hakitor Street, P.O. Box 10347, Haifa Bay, Haifa, ISR, 2624761
Taro Pharmaceutical Industries Ltd produces, researches, develops, and markets pharmaceutical products. Its primary focus includes semi-solid formulations, such as creams and ointments, and other dosage forms such as liquids, capsules, and tablets. The company is engaged in the dermatological and topical, cardiovascular, neuropsychiatric, and anti-inflammatory therapeutic categories. Geographically, it derives a majority of its revenue from the United States and also has a presence in Canada, Israel, and Other Countries.
Executives
Taro Pharmaceutical Industries (Taro Pharmaceutical Industries) Headlines
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
TARO has been successfully added to your